Dr. Hulgan has co-directed a CFAR Scientific Working Group and been a member of the Executive Committee. Dr. Hulgan’s research seeks to improve the health of persons with HIV by better understanding, predicting, preventing, and treating complications of HIV infection and antiretroviral therapy. An area of primary focus includes the field of translational mitochondrial genomics in HIV. Current phenotypes of interest include neurocognition and diabetes. The ultimate vision for this work is to provide new knowledge and tools (genomic and/or biological markers) that inform a “precision-medicine” approach to improve treatment and management decisions for clinical care- and thus the length and quality of life- of an aging population of HIV infected persons. Dr. Hulgan maintains an active clinical and teaching program, having cared for persons with HIV for almost more than 20 years, and serving as VA Infectious Disease Section Chief and mentoring fellows each year at the Nashville VA Hospital.